Roundtable discussion. Maximizing potential cost benefits of teicoplanin through appropriate usage.
Rybak
M J
MJ
School of Medicine, Wayne State University, Detroit, MI.
Allen
R
R
Arnow
P
P
Craven
P C
PC
Freeman
R
R
Grüneberg
R N
RN
Korin
J
J
Nightingale
C H
CH
Rubinstein
E
E
Schaison
G S
GS
D003363:Cost Control; D003428:Cross Infection; D016527:Drug Costs; D005572:Formularies, Hospital as Topic; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D016365:Liability, Legal; D017334:Teicoplanin / Q000008:administration & dosage / Q000191:economics*